| Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult (NCT01037114) | GlaxoSmithKline | 2010-01-27 |
| Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633 (NCT01086462) | GlaxoSmithKline | 2010-01-21 |
| A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers. (NCT01299597) | GlaxoSmithKline | 2010-01-18 |
| Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect (NCT01072162) | GlaxoSmithKline | 2010-01-12 |
| A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans (NCT01051700) | GlaxoSmithKline | 2010-01-12 |
| Efficacy Study in Lumbosacral Radiculopathy (NCT01110057) | GlaxoSmithKline | 2010-01-07 |
| Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis (NCT01018030) | GlaxoSmithKline | 2010-01-06 |
| First Time in Human Study of Intravenous Interleukin-18 Antibody (NCT01035645) | GlaxoSmithKline | 2010-01-05 |
| SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin (NCT01262989) | GlaxoSmithKline | 2010-01-04 |
| PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease (NCT01051622) | GlaxoSmithKline | 2010-01-01 |
| Survey on the Pharmacy Follow-up of Alli Purchasers (NCT01387243) | GlaxoSmithKline | 2010-01-01 |
| Regulatory TYKERB® Tablets PMS (NCT00975988) | GlaxoSmithKline | 2010-01-01 |
| Economic Analyses of the REDUCE Trial (NCT01337258) | GlaxoSmithKline | 2010-01-01 |
| A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo (NCT01072149) | GlaxoSmithKline | 2010-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD (NCT01039675) | GlaxoSmithKline | 2010-01-01 |
| European Cost of Asthma Treatment (NCT01376219) | GlaxoSmithKline | 2010-01-01 |
| Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term) (NCT01376271) | GlaxoSmithKline | 2010-01-01 |
| Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response (NCT01128569) | GlaxoSmithKline | 2010-01-01 |
| Hemorrhage Risk Prescribed Arixtra (NCT01064362) | GlaxoSmithKline | 2010-01-01 |
| A PET Study in Healthy Volunteers (NCT01424449) | GlaxoSmithKline | 2010-01-01 |
| A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation (NCT01021553) | GlaxoSmithKline | 2009-12-23 |
| A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers (NCT01371799) | GlaxoSmithKline | 2009-12-17 |
| 28-day Repeat Dose Study of GSK573719 (NCT01030965) | GlaxoSmithKline | 2009-12-15 |
| To Investigate the Clinical Efficacy of an Experimental Toothpaste (NCT01079910) | GlaxoSmithKline | 2009-12-09 |
| Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy (NCT01051063) | GlaxoSmithKline | 2009-12-09 |
| Effect of SRT2104 on Endotoxin-induced Inflammation (NCT01014117) | GlaxoSmithKline | 2009-12-09 |
| SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin (NCT01330303) | GlaxoSmithKline | 2009-12-08 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents (NCT00950612) | GlaxoSmithKline | 2009-12-08 |
| Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children (NCT01027845) | GlaxoSmithKline | 2009-12-08 |
| A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers (NCT01018628) | GlaxoSmithKline | 2009-12-07 |
| Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance (NCT01039805) | GlaxoSmithKline | 2009-12-01 |
| Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone (NCT01332370) | GlaxoSmithKline | 2009-12-01 |
| Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® (NCT01540734) | GlaxoSmithKline | 2009-12-01 |
| A Study to Compare Two Paracetamol Formulations. (NCT01592227) | GlaxoSmithKline | 2009-12-01 |
| Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose (NCT00972725) | GlaxoSmithKline | 2009-12-01 |
| Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia (NCT01009060) | GlaxoSmithKline | 2009-12-01 |
| Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend (NCT01540721) | GlaxoSmithKline | 2009-12-01 |
| PET Study to Study Tumour Apoptosis (NCT01428440) | GlaxoSmithKline | 2009-12-01 |
| The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial (NCT01000727) | GlaxoSmithKline | 2009-12-01 |
| Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) (NCT00964028) | GlaxoSmithKline | 2009-12-01 |
| Intranasal SB-705498 in Non-allergic Rhinitis Patients (NCT01439308) | GlaxoSmithKline | 2009-12-01 |
| Drug Use Investigation for ALLERMIST (NCT01376206) | GlaxoSmithKline | 2009-12-01 |
| Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children (NCT01014091) | GlaxoSmithKline | 2009-12-01 |
| Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) (NCT00996944) | GlaxoSmithKline | 2009-11-30 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine (NCT01021293) | GlaxoSmithKline | 2009-11-28 |
| Avandamet Bioequivalence Study Brazil - Fed Administration (NCT01332071) | GlaxoSmithKline | 2009-11-24 |
| Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination (NCT00985751) | GlaxoSmithKline | 2009-11-24 |
| A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263 (NCT01128621) | GlaxoSmithKline | 2009-11-23 |
| First Time in Human Study (NCT01031186) | GlaxoSmithKline | 2009-11-23 |
| An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma (NCT00992121) | GlaxoSmithKline | 2009-11-18 |
| Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children (NCT01003418) | GlaxoSmithKline | 2009-11-17 |
| A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib (NCT00996762) | GlaxoSmithKline | 2009-11-12 |
| Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali (NCT00985465) | GlaxoSmithKline | 2009-11-12 |
| Alcohol Interaction Study (NCT01181908) | GlaxoSmithKline | 2009-11-11 |
| Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older (NCT00979602) | GlaxoSmithKline | 2009-11-09 |
| Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM (NCT00969436) | GlaxoSmithKline | 2009-11-09 |
| Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult (NCT01000324) | GlaxoSmithKline | 2009-11-06 |
| Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers (NCT00996671) | GlaxoSmithKline | 2009-11-06 |
| Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects (NCT01000857) | GlaxoSmithKline | 2009-11-05 |
| Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease (NCT01009255) | GlaxoSmithKline | 2009-11-02 |
| Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder (NCT01000493) | GlaxoSmithKline | 2009-11-02 |
| Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use (NCT01332435) | GlaxoSmithKline | 2009-11-01 |
| Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies (NCT01332461) | GlaxoSmithKline | 2009-11-01 |
| A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype (NCT01495494) | GlaxoSmithKline | 2009-11-01 |
| Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric) (NCT01332422) | GlaxoSmithKline | 2009-11-01 |
| Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma (NCT01000506) | GlaxoSmithKline | 2009-11-01 |
| Post-operative Dental Pain Study Comparing Two Different Dosage of Analgesic Efficacy (NCT01075243) | GlaxoSmithKline | 2009-11-01 |
| SCOT Registry: Small Cell Lung Cancer Treatment and Outcome (NCT00997061) | GlaxoSmithKline | 2009-11-01 |
| Relenza® Sentinel Site Monitoring Program in Japan (NCT01199744) | GlaxoSmithKline | 2009-11-01 |
| Enamel Remineralization Potential of Dentifrices in Situ (NCT01128946) | GlaxoSmithKline | 2009-11-01 |
| A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc. (NCT01039610) | GlaxoSmithKline | 2009-11-01 |
| Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians (NCT01777074) | GlaxoSmithKline | 2009-11-01 |
| Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital (NCT01014988) | GlaxoSmithKline | 2009-11-01 |
| A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions (NCT01476215) | GlaxoSmithKline | 2009-11-01 |
| Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor (NCT01037127) | GlaxoSmithKline | 2009-11-01 |
| A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations (NCT01476189) | GlaxoSmithKline | 2009-11-01 |
| Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom (NCT00996853) | GlaxoSmithKline | 2009-10-31 |
| Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease (NCT00984659) | GlaxoSmithKline | 2009-10-29 |
| Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects (NCT00996125) | GlaxoSmithKline | 2009-10-24 |
| Paxil CR Bioequivalence Study Brazil - Fed Administration (NCT01339247) | GlaxoSmithKline | 2009-10-20 |
| Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age (NCT00976820) | GlaxoSmithKline | 2009-10-20 |
| Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01054885) | GlaxoSmithKline | 2009-10-19 |
| Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study (NCT01018186) | GlaxoSmithKline | 2009-10-19 |
| A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes (NCT00976261) | GlaxoSmithKline | 2009-10-17 |
| SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS (NCT00996840) | GlaxoSmithKline | 2009-10-16 |
| Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People (NCT00992784) | GlaxoSmithKline | 2009-10-15 |
| An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836. (NCT00996268) | GlaxoSmithKline | 2009-10-15 |
| First Time in Human Study With GSK1325756 (NCT01209052) | GlaxoSmithKline | 2009-10-15 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes (NCT00992511) | GlaxoSmithKline | 2009-10-14 |
| Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children (NCT00980005) | GlaxoSmithKline | 2009-10-13 |
| Study to Evaluate Immunological Equivalence Between Two Investigational Influenza Vaccines in Adults (H1N1) (NCT00979407) | GlaxoSmithKline | 2009-10-12 |
| Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination (NCT00984139) | GlaxoSmithKline | 2009-10-12 |
| Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days (NCT00989404) | GlaxoSmithKline | 2009-10-12 |
| Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older (NCT00985088) | GlaxoSmithKline | 2009-10-11 |
| A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation (NCT00910962) | GlaxoSmithKline | 2009-10-08 |
| Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children (NCT00985790) | GlaxoSmithKline | 2009-10-08 |
| Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults (NCT00989287) | GlaxoSmithKline | 2009-10-07 |
| A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01053988) | GlaxoSmithKline | 2009-10-05 |
| A Study of GSK573719 in Healthy Japanese Male Subjects (NCT01013974) | GlaxoSmithKline | 2009-10-05 |
| Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) (NCT00989612) | GlaxoSmithKline | 2009-10-01 |